Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompleted
NCT00337649Phase 1, Phase 2Updated Apr 28, 2023
Sponsor: Hoffmann-La Roche
Breast Cancer
Spain
Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes MellitusCompleted
NCT00057304Phase 2Updated Apr 28, 2023
Sponsor: Hoffmann-La Roche
Diabetes
United States, Bulgaria, Estonia, Mexico, Panama +4 more
A Study To Investigate The Safety, Tolerability And Pharmacokinetics (PK) Of RO7223280 Following Intravenous Administration In Healthy ParticipantsCompleted
NCT04605718Phase 1Updated Apr 18, 2023
Sponsor: Hoffmann-La Roche
Healthy Volunteers
United States
Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma ParticipantsCompleted
NCT02536664N/AUpdated Apr 18, 2023
Sponsor: Hoffmann-La Roche
Follicular Lymphoma
Germany
Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)Completed
NCT02028884Phase 3Updated Apr 18, 2023
Sponsor: Hoffmann-La Roche
Neuromyelitis Optica (NMO) · NMO Spectrum Disorder (NMOSD)
United States, France, Germany, Hungary, Italy +6 more
A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has SpreadTerminated
NCT02322814Phase 2Updated Apr 13, 2023
Sponsor: Hoffmann-La Roche
Breast Cancer
United States, Australia, Belgium, Czechia, France +8 more
Medico-economic Interest of the Protein S100b in Mild Head Trauma Under Anti-thromboticsCompleted
NCT04305821N/AUpdated Apr 12, 2023
Sponsor: Rennes University Hospital
Mild Head Injury · Anticoagulant · Antiplatelet
France
A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological CancersCompleted
NCT03073525Phase 2Updated Apr 5, 2023
Sponsor: Gradalis, Inc.
Advanced Gynecological Cancers · Ovarian Cancer · Cervical Cancer · Uterine Cancer
United States
A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaCompleted
NCT01164891Phase 1Updated Apr 5, 2023
Sponsor: Hoffmann-La Roche
Malignant Melanoma
Switzerland
Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer MaterialCompleted
NCT05798312NAUpdated Apr 4, 2023
Sponsor: Medicos e Investigadores en la Lucha contra el Cancer de Mama
Breast Cancer · Knowledge, Attitudes, Practice · Patient Empowerment · Patient Satisfaction
Mexico
The Effect of HealthWear on Short-Term Weight LossCompleted
NCT00177593Phase 1, Phase 2Updated Apr 3, 2023
Sponsor: University of Pittsburgh
Weight Loss · Obesity
United States
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal WomenCompleted
NCT00545077Phase 3Updated Mar 31, 2023
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer
Germany, Spain
First Line Therapy of Advanced Stage Follicular Lymphoma in Patients < 60 Years Not Eligible fo Standard Immunochemotherapy and in All Patients ≥ 60 YearsCompleted
NCT03492775Phase 2Updated Mar 31, 2023
Sponsor: Prof. Dr. Wolfgang Hiddemann
Indolent Non-hodgkin Lymphoma
Germany
Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer PatientsCompleted
NCT00130533Phase 3Updated Mar 31, 2023
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer
Spain
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast CancerCompleted
NCT00129935Phase 3Updated Mar 31, 2023
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer
Spain
A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL)Completed
NCT01238692Phase 2Updated Mar 24, 2023
Sponsor: Sarit Assouline
Diffuse Large B Cell Lymphoma
Canada
DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)Completed
NCT04409925Phase 1Updated Mar 17, 2023
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
COVID-19 Infection
Canada
A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast CancerCompleted
NCT04584112Phase 1Updated Mar 15, 2023
Sponsor: Hoffmann-La Roche
Triple-Negative Breast Cancer
United States, Australia, Brazil, Germany, Russia +3 more
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]Completed
NCT02409342Phase 3Updated Mar 15, 2023
Sponsor: Hoffmann-La Roche
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
United States, Brazil, China, France, Germany +14 more
A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in ArgentinaCompleted
NCT03321695N/AUpdated Mar 13, 2023
Sponsor: Hoffmann-La Roche
Carcinoma, Non-small-cell Lung
Argentina
Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy ParticipantsCompleted
NCT04718181Phase 1Updated Mar 13, 2023
Sponsor: Hoffmann-La Roche
Muscular Atrophy, Spinal
United States
A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in ArgentinaCompleted
NCT03330886N/AUpdated Mar 13, 2023
Sponsor: Hoffmann-La Roche
Urothelial Carcinoma
Argentina
Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and MetastasisCompleted
NCT01377363N/AUpdated Mar 10, 2023
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer
Spain
Add Vitamin D With Standard of Care for Chronic Hepatitis C PatientsCompleted
NCT01439776Phase 4Updated Mar 6, 2023
Sponsor: Hanyang University
Chronic Hepatitis C
South Korea
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast CancerCompleted
NCT00129922Phase 3Updated Mar 6, 2023
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer
Spain

Previous page Next page